Since liver disease from different aetiologies are shown to be associated with immune reactivity or immune suppression [96], even in today’s mass immunisation context, our data suggest hospitals around the world, and perhaps particularly in Spain and Italy, should consider regular follow-ups of those past COVID-19 patients that presented high levels of liver damage markers (ALT, ASD or LHD) after vaccination. This evidence concerns the gene GPT and liver disorder.